Home › News and Press › Page 2

News and Press releases

View all News Press releases

Oxcia is focusing the development of OXC-101 on hematological cancers

October 4, 2024 · News and Press

Oxcia presents OXC-201 at ICLAF 2024

September 4, 2024 · News and Press

New publications in peer-reviewed scientific journals support the potential for OXC-101 as a novel anti-cancer therapy

June 11, 2024 · News and Press

Patent approval now also secured in the US, the largest IPF market

May 17, 2024 · News and Press

Another key milestone for OXC-201 – patent approval in China

May 3, 2024 · News and Press

Key milestone for OXC-101 – study approval in South Africa

March 21, 2024 · News and Press

Presentation of OXC-201 at Respiratory conference March 7-8th

February 29, 2024 · News and Press

Oxcia AB Publishes Year-End Report for 2023

February 22, 2024 · News and Press

Key milestone for OXC-201 – patent approval in Japan

February 21, 2024 · News and Press

World Cancer day

February 4, 2024 · News and Press

Oxcia’s CEO speaker at DDR Inhibitors Summit

January 22, 2024 · News and Press

Oxcia AB (publ) publishes interim report fort the third quarter 2023

November 23, 2023 · News and Press

Search